Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: J Nucl Cardiol. 2018 Dec 19;26(1):158–173. doi: 10.1007/s12350-018-01552-4

Figure 11.

Figure 11.

18F-florbetapir PET/CT imaging in patients with AL, ATTR, and no-amyloidosis. Images are displayed as axial CT transmission (A), axial emission (B), fused transmission/emission (C), and a maximum intensity projection image (D). Both AL (top left), ATTR (top right) images show intense 18F-florbetapir uptake in the left ventricle. The patient without amyloidosis, volunteer, (bottom), showed no myocardial uptake of 18F-florbetapir.